The Histone Deacetylase Inhibitor Romidepsin Spares Normal Tissues While Acting as an Effective Radiosensitizer in Bladder Tumors in Vivo

PURPOSE: Muscle-invasive bladder cancer has a 40% to 60% 5-year survival rate with radical treatment by surgical removal of the bladder or radiation therapy–based bladder preservation techniques, including concurrent chemoradiation. Elderly patients cannot tolerate current chemoradiation therapy reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Paillas, Salome, Then, Chee K., Kilgas, Susan, Ruan, Jia-Ling, Thompson, James, Elliott, Amy, Smart, Sean, Kiltie, Anne E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier, Inc 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181176/
https://www.ncbi.nlm.nih.gov/pubmed/31987970
http://dx.doi.org/10.1016/j.ijrobp.2020.01.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181176/
https://www.ncbi.nlm.nih.gov/pubmed/31987970
http://dx.doi.org/10.1016/j.ijrobp.2020.01.015

Ejemplares similares